CRNX
Crinetics Pharmaceuticals Inc

1,440
Mkt Cap
$4.5B
Volume
640,292.00
52W High
$53.55
52W Low
$24.10
PE Ratio
-10.27
CRNX Fundamentals
Price
$46.55
Prev Close
$47.39
Open
$46.98
50D MA
$44.94
Beta
1.16
Avg. Volume
1.56M
EPS (Annual)
-$3.69
P/B
4.11
Rev/Employee
$2,377.57
Loading...
Loading...
News
all
press releases
174,077 Shares in Crinetics Pharmaceuticals, Inc. $CRNX Purchased by Rice Hall James & Associates LLC
Rice Hall James & Associates LLC acquired a new position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) during the 3rd quarter, according to the company in its most recent...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Squarepoint Ops LLC Has $1.21 Million Stake in Crinetics Pharmaceuticals, Inc. $CRNX
Squarepoint Ops LLC lessened its holdings in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) by 69.8% during the second quarter, according to the company in its most recent...
MarketBeat·11d ago
News Placeholder
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines PR Newswire...
PR Newswire·13d ago
News Placeholder
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen brokerages that are currently covering the firm, MarketBeat...
MarketBeat·13d ago
News Placeholder
What is HC Wainwright's Estimate for CRNX FY2025 Earnings?
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) - Equities researchers at HC Wainwright reduced their FY2025 earnings per share estimates for shares of Crinetics Pharmaceuticals in a...
MarketBeat·15d ago
News Placeholder
Sanders Morris Harris LLC Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX
Sanders Morris Harris LLC purchased a new position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with...
MarketBeat·15d ago
News Placeholder
JPMorgan Chase & Co. Has $9.55 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNX
JPMorgan Chase & Co. lifted its stake in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) by 25.0% during the 2nd quarter, according to the company in its most recent 13F filing...
MarketBeat·22d ago
News Placeholder
Crinetics Pharmaceuticals, Inc. $CRNX Stock Holdings Increased by Walleye Capital LLC
Walleye Capital LLC increased its stake in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) by 53.5% in the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·25d ago
News Placeholder
Decheng Capital LLC Cuts Stake in Crinetics Pharmaceuticals, Inc. $CRNX
Decheng Capital LLC cut its holdings in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) by 19.6% during the second quarter, according to the company in its most recent filing...
MarketBeat·28d ago
News Placeholder
XTX Topco Ltd Acquires Shares of 34,013 Crinetics Pharmaceuticals, Inc. $CRNX
XTX Topco Ltd bought a new position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·30d ago
<
1
2
...
>

Latest CRNX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.